ATE263575T1 - Arzneimittel zur lokalen anwendung, das fibrinogen, thrombin, transglutaminasen und proteinaseinhibitoren enthält - Google Patents

Arzneimittel zur lokalen anwendung, das fibrinogen, thrombin, transglutaminasen und proteinaseinhibitoren enthält

Info

Publication number
ATE263575T1
ATE263575T1 AT00936524T AT00936524T ATE263575T1 AT E263575 T1 ATE263575 T1 AT E263575T1 AT 00936524 T AT00936524 T AT 00936524T AT 00936524 T AT00936524 T AT 00936524T AT E263575 T1 ATE263575 T1 AT E263575T1
Authority
AT
Austria
Prior art keywords
transglutaminases
thrombin
medicinal product
topical use
proteinase inhibitors
Prior art date
Application number
AT00936524T
Other languages
English (en)
Inventor
Johann Eibl
Original Assignee
Bio & Bio Licensing Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AT0089599A external-priority patent/AT500670A1/de
Application filed by Bio & Bio Licensing Sa filed Critical Bio & Bio Licensing Sa
Application granted granted Critical
Publication of ATE263575T1 publication Critical patent/ATE263575T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36Blood coagulation or fibrinolysis factors
    • A61K38/363Fibrinogen

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
AT00936524T 1999-05-19 2000-05-19 Arzneimittel zur lokalen anwendung, das fibrinogen, thrombin, transglutaminasen und proteinaseinhibitoren enthält ATE263575T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AT0089599A AT500670A1 (de) 1999-05-19 1999-05-19 Arzneimittel zur lokalen anwendung
PCT/AT2000/000141 WO2000071153A2 (de) 1999-05-19 2000-05-19 Arzneimittel zur lokalen anwendung, das fibrinogen, thrombin, transglutaminasen und proteinaseinhibitoren enthält
EP00936524A EP1183043B1 (de) 1999-05-19 2000-05-19 Arzneimittel zur lokalen anwendung, das fibrinogen, thrombin, transglutaminasen und proteinaseinhibitoren enthält

Publications (1)

Publication Number Publication Date
ATE263575T1 true ATE263575T1 (de) 2004-04-15

Family

ID=25594244

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00936524T ATE263575T1 (de) 1999-05-19 2000-05-19 Arzneimittel zur lokalen anwendung, das fibrinogen, thrombin, transglutaminasen und proteinaseinhibitoren enthält

Country Status (1)

Country Link
AT (1) ATE263575T1 (de)

Similar Documents

Publication Publication Date Title
DE50005999D1 (de) Arzneimittel zur lokalen anwendung, das fibrinogen, thrombin, transglutaminasen und proteinaseinhibitoren enthält
FI965039L (fi) Uusia trombiini-inhibiittoreita, niiden valmistus ja käyttö
IL156096A0 (en) New mandelic acid derivatives and their use as thrombin inhibitors
HUP0200347A2 (en) N-cyanomethylamides as protease inhibitors, pharmaceutical compositions containing them and their use
HUP0300855A3 (en) Peptidmomimetic protease inhibitors, pharmaceutical compositions and their use
EE05157B1 (et) N-[(asendatud bensüül)-4-piperidinüüli v?i pürrolidinüül]aminohüdroksüalkoksüfenüülide derivaadid, meetod nende valmistamiseks ning nende kasutamine meditsiinis
HUP0103283A3 (en) Pyrazinone protease inhibitors, pharmaceutical compositions containing them and use of the compounds
EE9700354A (et) Trombiini uued inhibiitorid, nende saamine ja kasutamine
EP1344780A4 (de) Glucopyranosyloxybenzylbenzolderivate, medizinische zusammensetzungen, die diese verbindungen enthalten, und zwischenprodukte für deren herstellung
NO20024528L (no) Proteaseinhibitor, farmasoytisk sammensetning og anvendelse av forbindelsen
HUP0101616A3 (en) Substituted benzamides, their production and their use as cysteine protease inhibitors
DE69923810D1 (de) Blutstillendes Mittel
HUP0000965A3 (en) Pyrrolidine derivatives having phospolipase a2 inhibitory activity and pharmaceutical compositions containing the same
EE200100391A (et) Peptidüül-heterotsüklilised ketoonid, nende kasutamine ja farmatseutiline kompositsioon
AU2002230836A1 (en) Benzylamine derivatives and their use as thrombin inhibitors
IL156577A0 (en) Selective cathepsin s inhibitors and pharmaceutical compositions containing the same
PL349769A1 (en) New amidinobenzylamine derivatives and their use as thrombin inhibitors
HUP0100082A3 (en) Thrombin inhibitor, peptide derivatives, pharmaceutical compositions comprising thereof and their use
AU5693101A (en) New thiochromane derivatives and their use as thrombin inhibitors
DE60102336D1 (de) Kautschukzusammensetzung die Polymaleimid enthält und Reifen
AU2002223313A1 (en) Protease inhibitors and their pharmaceutical uses
NO995838D0 (no) Nye heteroetynylenforbindelser og farmasöytiske og kosmetiske preparater inneholdende de samme
ATE263575T1 (de) Arzneimittel zur lokalen anwendung, das fibrinogen, thrombin, transglutaminasen und proteinaseinhibitoren enthält
HUP0203697A3 (en) Novel integrin alphavbetha3 inhibitors, pharmaceutical compositions containing them and their use
DE69807712D1 (de) Zusammensetzung zur mundhygiene, die eine bakterielle pullulanase und dextranase enthält